1. Merck Strengthens Cancer Drug Pipeline With Peloton Therapeutics Acquisition  Barron's
2. Merck buys Peloton to expand its kidney cancer treatment portfolio  Reuters
3. Merck buys Peloton Therapeutics to expand its kidney cancer treatment portfolio  CNBC
4. Pharma giant Merck makes $2 billion bet on a Dallas-based cancer drug developer  Dallas News
5. Merck to Buy Peloton for Up to $2.2 Billion, Day Before IPO  Washington Post
6. View full coverage on Google News

Merck & Co., Inc. MRK announced a definitive agreement to buy small private cancer biotech, Peloton Therapeutics for an upfront payment of $1.05 billion in ...

GENEVA (Reuters) - Democratic Republic of Congo called on Wednesday for Merck's experimental Ebola vaccine to be fully licensed to facilitate its use in the ...

WASHINGTON (Reuters) - The U.S. Supreme Court on Monday gave Merck & Co a new opportunity to avoid lawsuits accusing the company of failing to properly ...

In the recently decided Merck Sharp & Dohme Corporation v. Albrecht et al., the Supreme Court clarified the requirements for when state failure-to-warn claims ...

The index suffered a difficult week as investors braced for a protracted U.S.-China trade war. The decision to effectively ban Huawei weighed heavily on tech ...

Months after the FDA sanctioned the approval of Roche's runner up checkpoint inhibitor Tecentriq in combination with Celgene's Abraxane for treatment naive ...

Merck KGaA and its partner Pfizer obtained FDA approval for Bavencion in combination with Inlyta to treat first-line patients with advanced kidney cancer. FDA a.

Good afternoon, readers. I read something pretty troubling (if not surprising) this morning. And, yes, it has to do with my generation, AKA the millennial folk.

(Reuters) - Merck & Co Inc said on Monday its blockbuster cancer drug Keytruda failed to meet the main goal of a late-stage study testing the drug as a ...

Atlantic Equities upgraded its rating on shares of Merck to overweight on Monday, saying it is ?best positioned? to grow among large pharmaceutical companies ...

See which stocks are posting big moves after the bell on Monday, May 20.

A Merck subsidiary will acquire Peloton Therapeutics Inc., a privately held clinical-stage biopharmaceutical company that is testing an oral hypoxia-inducible ...

Merck & Co. on Tuesday said it is revamping its manufacturing and supply network, with plans to close or divest facilities and reduce employee headcount.

For a CEO to focus public remarks on science and scientists is rare.

Merck R&D chief Roger Perlmutter has found another biotech company to love. And he's buying it, snatching it out of the IPO queue. The pharma giant said ...

Amid ongoing controversy in the Tennessee House of Representatives, Speaker Glen Casada has resigned from his job selling pharmaceuticals for Merck & Co.

A healthcare and pharmaceutical manufacturer in Rockingham County will be investing $1 billion and adding nearly 100 jobs over the next three years thanks to ...

Four giant companies now dominate global vaccine sales. With newer and more expensive vaccines becoming available, the market value of vaccines could ...

Check out the companies making headlines before the bell: Home Depot ? Home Depot reported first quarter profit of $2.27 per share, 9 cents a share above ...

Cancer-therapy giant Merck & Co. is scheduled to report its first-quarter financial results on Tuesday ahead of the opening bell.

Merck has moved up the past few years, due mostly to booming sales of Keytruda, its immune stimulator to treat cancer. Technically, I suspect that its multi-mon.

Germany-based pharmaceuticals company Merck has revamped its hedging policy to protect against unfavorable shifts in currency-exchange rates sparked by ...

Merck (NYSE:MRK) recently reported its Q1 2019 results, which were above our estimates. This note details the company's Q1 performance, and Trefis' ...

A Phase 3 clinical trial, KEYNOTE-119, evaluating Merck's (MRK) Keytruda (pembrolizumab) as monotherapy for the second- or third-line treatment of metasta.

Merck & Co. disclosed today it will restructure its manufacturing and supply network over the next four years, in a cost-cutting move designed to save the pharma ...

Merck & Co. Inc. shares rose 2.6% in premarket trade Tuesday, after the drug company posted stronger-than-expected earnings for the first quarter and...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 20) ...

The New Jersey Supreme Court has blocked a Merck shareholder's plans for a deep dive into the company's records related to the acquisition of another drug ...

Merck KGaA has revised the bispecific immuno-oncology antibody agreement it struck with F-star in 2017. The Big Pharma has exercised its option on a ...

Gov. Ralph Northam visited the Merck manufacturing plant in Rockingham County on Monday to announce the pharmaceutical company's plans to expand its ...

Merck's strategy of ?investing thoughtfully? in science-based R&D is paying off, says CEO Kenneth C. Frazier. For the first quarter, the Kenilworth, N.J.-based ...

Like all veterinarians, Doctor Bob wants to make it as easy as possible for his patients to get the best products on the market. But it can be scary for families to ...

Merck & Co. filed with the U.S. Securities and Exchange Commission that it plans an extensive restructuring of its manufacturing and supply network. This will, it ...

The three big pharmaceutical companies ? Eli Lilly, Merck, and Pfizer ? are due to release their results on Tuesday. Although health care had a fairly good ...

In this regular series, I provide a brief summary of biotech news tidbits that I found interesting. Merck announced encouraging results from phase 2 study of V1.

Here are the biggest calls on Wall Street on Monday.

CNBC's Meg Tirrell joins "Squawk Box" to discuss how earnings results from Pfizer, Merck and Eli Lilly compare.

Funds raised will go toward *service* dogs in training.

Merck & Co. has reached an agreement to acquire privately held biopharmaceutical company Peloton Therapeutics for an upfront payment of $1.05 billion in ...

NEW YORK (Reuters) - Merck & Co said on Wednesday it has increased production of the measles vaccine to meet an uptick in demand in the United States in ...

Merck KGaA (MRK.XE) said Tuesday that first-quarter sales increased, while its net profit fell sharply and backed its targets for the year. Sales for the...

Merck revenue expected to rise 4.3% to $10.5 billion....MRK.

Scientists have long hoped for implants that can treat or prevent HIV, replacing daily pill regimens. Merck may soon make that dream a reality.

A year and a half after scoring an approval to use Keytruda in third-?line gastric cancer, Merck has run into a wall trying to apply the PD-?1 star in the frontline ...

Cancer patients and caregivers recount stories and offer advice to their former selves in personal letters, looking back to when they were first diagnosed, ...

Pfizer earnings and Merck earnings beat, with the Dow drug giants giving decent outlooks. Pfizer stock, Merck stock rose. Eli Lilly stock fell on revenue.

Merck & Co Inc. MRK has announced this week that it will be buying Peloton Therapeutics in a transaction valued at $1.05 billion. With the transaction, the ...

FRANKFURT, May 14 (Reuters) - Germany's Merck KGaA , which is taking over U.S. electronic chemicals maker Versum Materials, said it expected a slight ...

V114 Met Primary Endpoint by Demonstrating Noninferiority to PCV13 for all Shared Serotypes, and an Immune Response for Two Additional Serotypes.

Merck's licensing process is underway but it was unclear how long it would take, he said. Congo's government had not discussed or requested the introduction ...

Merck debuts diabetes documentary 'A Touch of Sugar'. From PR Week.

Gemmer Asset Management Llc decreased its stake in Merck & Co Inc (MRK) by 82.64% based on its latest 2018Q4 regulatory filing with the SEC. Gemmer ...

Merck & Co Inc. (NYSE:MRK) Q1 2018 Earnings Conference Call April 30, 2019 8:00 AM ET Company Participants Teri Loxam - SVP, Investor Relations and ...

BP, Merck, Blue Apron, Vodafone and Walmart are the companies to watch.

Two big pharma titans are battling for supremacy in the field of oncology immunotherapy. From the looks of it, Kenilworth, New Jersey-based Merck & ...

Fundamentally, MoneyGram International, Inc. (NASDAQ:MGI) looks appealing. Its stock trades at 0.07 times the company's sales over the past 12 months.

Merck (MRK) announces positive results from a Phase 3 clinical trial evaluating BELSOMRA (suvorexant) for the treatment of insomnia in people with mild-to-

Merck Foundation (www.Merck-Foundation.com), the philanthropic arm of Merck KGaA Germany marked 'World Hypertension Day 2019' by building ...

Drug firm Merck Ltd on Tuesday said it has been renamed as Procter & Gamble Health Ltd following P&G's global acquisition of the consumer health business of ...

Chicago, IL ? May 8, 2019 ? Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ...

Net Sales at Rs 231.03 crore in March 2019 down 23.29% from Rs. 301.17 crore in March 2018. Quarterly Net Profit at Rs. 40.71 crore in March 2019 up 79.22% ...

Merck KGaA reports a 15% year-on-year growth in its Process Solutions business and looks to its next-generation bioprocessing platform BioContinuum to ...

Merck & Co. will invest $1 billion over the next three years to increase production of its human papillomavirus (HPV) vaccine Gardasil at its Rockingham County ...

WEYERS CAVE, Va. (WHSV) ? As part of Merck's plan to hire an additional 100 workers at its Elkton plant, the pharmaceutical company also announced a ...

Curious about what Jim Cramer's keeping an eye on during the middle of earnings season....MCD.

The report identifies the increasing focus on the self-management of diabetes to be one of the major factors that will have a positive impact on the growth of this ...

The approval marks the first time the FDA has approved a checkpoint inhibitor for the treatment of advanced renal cell cancer.

Merck Foundation (www.Merck-Foundation.com), the philanthropic arm of Merck KGaA Germany underscored their commitment to build healthcare capacity in ...

The ?Biofilter Systems Market? report gives a weighty source to assess the market and other fundamental technicalities identifying with it. The examination ...

Clovis Oncology CEO Patrick Mahaffy $CLVS has engineered a risky gamble to pay for his big Phase III study combining his PARP Rubraca with Bristol-?Myers ...

SAN JOSE, Calif., May 6, 2019 /PRNewswire/ --Intermolecular, Inc. (NASDAQ: IMI) has signed a definitive agreement pursuant to which a wholly owned ...

BTK inhibitors are already establishing themselves as important new drugs in cancer, but Merck KGaA has the first data suggesting they could also play a role in ...

Hipgnosis Songs Fund Limited has acquired a music catalog comprised of 144 songs from Jamie Scott, the UK songwriter and record producer responsible for ...

Among noteworthy research news last week was new data for The Medicines Company's cholesterol lowerer inclisiran showing the drug has dosing advantage.

Becker Capital Management Inc decreased its stake in Merck & Co Inc Com (MRK) by 27.24% based on its latest 2018Q4 regulatory filing with the SEC. Becker ...

Looking at top Wall Street opinions, Merck & Co., Inc. (NYSE: MRK) has recently made its way into the research list of Atlantic Equities ? signaling that their ...

Abner Herrman & Brock Llc increased its stake in Merck & Co Inc (MRK) by 16.02% based on its latest 2018Q4 regulatory filing with the SEC. Abner Herrman ...

Bremer Trust National Association increased its stake in Merck & Co Inc (MRK) by 45.81% based on its latest 2018Q4 regulatory filing with the SEC. Bremer ...

For Immediate Release. Chicago, IL ? May 6, 2019 ? Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research ...

Argyll Research Llc increased its stake in Tc Pipelines Lp (TCP) by 0.76% based on its latest 2018Q4 regulatory filing with the SEC. Argyll Research Llc bought ...

Jim Cramer weighs in on Arena Pharmaceuticals, DaVita, Merck, Abbott Laboratories, IAC Interactive, Yext and more....ARNA.

Global Micro-filtration Filter Cartridges Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024 recently arrived in the mrinsights.biz list ...

Lourd Capital Llc decreased its stake in Merck & Co Inc (MRK) by 44.68% based on its latest 2018Q4 regulatory filing with the SEC. Lourd Capital Llc sold 6483 ...

Suntrust Banks Inc increased its stake in Mastercard Incorporated (MA) by 2.04% based on its latest 2018Q4 regulatory filing with the SEC. Suntrust Banks Inc ...

Merck's Keytruda drug failed to meet the main goal of a late-stage study testing it as a standalone treatment for an aggressive type of breast cancer.

Diligent Investors Llc decreased its stake in Merck & Co Inc (MRK) by 33.35% based on its latest 2018Q4 regulatory filing with the SEC. Diligent Investors Llc ...

Diligent Investors Llc decreased its stake in Merck & Co Inc (MRK) by 33.35% based on its latest 2018Q4 regulatory filing with the SEC. Diligent Investors Llc ...

Research For Markets, is pleased to announce this latest publication, the In-Vitro Fertilization Market report contains all the figures necessitated to excel the ...

MALVERN, PA?Since 2006, building products company Saint-Gobain has encouraged innovation through an external ventures incubator called Saint-Gobain ...

Virginia Governor Ralph Northam announced that Merck & Co., Inc., plans to invest up to $1 billion dollars over the next 3 years to expand its vaccine ...

The World Health Organization announced Tuesday it is going to substantially ramp up the number of people eligible to be vaccinated against Ebola 4 in a bid to ...

The ?Cartridge Filters Market? far and wide is a standout amongst the most blossoming and colossally sorted division involving. This worldwide Cartridge Filters ...

The ?Hair Loss Medications Market? far and wide is a standout amongst the most blossoming and colossally sorted division involving. This worldwide Hair Loss ...

The following slide deck was published by MERCK Kommanditgesellschaft auf Aktien in conjunction with their 2019 Q1 earnings call.

Morgan Stanley set a ?96.00 ($111.63) price objective on Merck KGaA (FRA:MRK) in a report published on Friday, May 17th, Borsen Zeitung reports.

Envestnet Asset Management Inc increased its stake in Simon Ppty Group Inc New (SPG) by 1225.48% based on its latest 2018Q4 regulatory filing with the SEC ...

There are many different tools to determine whether a company is profitable or not. One of the most popular ratios is the ?Return on Assets? (aka.

The global ?Vascular Endothelial Growth Factor Inhibitor Market? research report comprises of the basic insights that are relevant to the global market. The report ...

The Global Stainless Steel Bioreactors Market report data always remains relevant to the market and consists of market dynamics, prospects, starts, market ...